Where does Taiwan RedEye Biomedical Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Taiwan RedEye Biomedical Inc. ranks #19,214 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Taiwan RedEye Biomedical Inc. hold?

Taiwan RedEye Biomedical Inc. holds 15 US utility patents granted between 2020 and 2024, spanning 12 technology areas.

What is Taiwan RedEye Biomedical Inc.'s Innovation Score?

Taiwan RedEye Biomedical Inc. has an Innovation Score of 48.4 out of 100 (top 17% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Taiwan RedEye Biomedical Inc. focus on?

Taiwan RedEye Biomedical Inc.'s top technology area is G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties) with 14 patents, ranking #1,082 of 7,863 assignees active in that subclass. Grants appear in 12 CPC subclasses total.

Is Taiwan RedEye Biomedical Inc.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Taiwan RedEye Biomedical Inc..

What does claim depth mean for Taiwan RedEye Biomedical Inc.'s patents?

Taiwan RedEye Biomedical Inc.'s patents average 13.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Taiwan RedEye Biomedical Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Taiwan RedEye Biomedical Inc.

USPTO PatentsView assignee record - 15 granted patents across 12 technology areas, recorded in grant years 2020–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Taiwan ranks #19,214 of 49,997 tracked US assignees by granted-patent volume, with 15 patents across 12 technology areas.

#19,214
of 49,997 US assignees by volume: Top 17%
by Innovation Score (48.4/100): 13.8
avg claims per patent

USPTO PatentsView assignee plate

Corpus R19214 · Foreign Corporation #19,214 · 15 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 15 grants
MID-PACK #19,214/49,997
PHOTO-FINISH Taheri LaDuca
CPC-FOCUS G01N · 12 areas
INNOV-PAR 48.4/100
CLAIMS-RICH 13.8 claims/avg
TYPE-FRNCORP Foreign Corp
SPAN-YRS 2020–2024 · 5y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Taheri LaDuca LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Taiwan’s 48.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.6 pts (20%) Velocity 18.3 pts (38%) Breadth 12.2 pts (25%) Claim depth 8.3 pts (17%)

Qualcomm Incorporated · highest

85
Taiwan RedEye… · this assignee

48
3D Lighting… · lowest

7

What this shows Taiwan's Innovation Score is 48.4/100 (top 17% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Taiwan?

Each dot is one of Taiwan’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Taiwan’s own 13.8 claims/patent is at or below the 16.5 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Taiwan vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Taiwan's grants concentrate

Taiwan RedEye Biomedical Inc. is a focused PatentsView assignee: 12 CPC subclasses with 93.3% of grants classified under G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties). Peak complete grant year is 2024 (5 grants) versus a trough of 1 in 2021. By volume, Taiwan sits between TVI Entwicklung & Produktion GMBH and Tectum Holdings, Inc..

Taiwan's three-year grant acceleration

Taiwan RedEye Biomedical Inc. shows 11 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

TVI Entwicklung &…

15
TVU Networks

15
Ty-crop Manufactu…

15
Taheri Laduca

15
Tala Energy

15
Tapestry Pharmace…

15
Technische Univer…

15
Tectum Holdings

15
Taiwan Redeye Bio… ◀

15

What this shows Taiwan holds 15 patents at rank #19,252, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Taiwan

By rank, the assignees closest to #19,252 in granted patent volume.

Leaders in G01N (Investigating OR Analysing Materials BY Determining Their…)

Other assignees with the most granted patents in Taiwan's primary technology class.

Taiwan's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

48 Top 17% higher than 83% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2020–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table

Taiwan RedEye Biomedical Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2020	3	20.0%
2021	1	6.7%
2022	3	20.0%
2023	3	20.0%
2024	5	33.3%

Which technologies does Taiwan RedEye Biomedical Inc. patent most?

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 14

A61B - DIAGNOSIS; SURGERY; Identification 4

E03D - Water-closets OR Urinals With Flushing DEVICES; Flushing Valves Therefor 3

G01J - Measurement OF Intensity, Velocity, Spectral Content, Polarisation, Phase OR Pulse Characteristics OF Infrared, Visible OR Ultraviolet LIGHT; COLORIMETRY; Radiation Pyrometry 3

G02B - Optical Elements, Systems OR Apparatus 2

H01L - Semiconductor Devices NOT Covered BY Class H10 1

H10F - Inorganic Semiconductor Devices Sensitive TO Infrared Radiation, Light, Electromagnetic Radiation OF Shorter Wavelength OR Corpuscular Radiation 1

G06F - Electric Digital Data Processing 1

G09G - Arrangements OR Circuits FOR Control OF Indicating Devices Using Static Means TO Present Variable Information 1

A47K - Sanitary Equipment NOT Otherwise Provided FOR ; Toilet Accessories 1

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 1

G06N - Computing Arrangements Based ON Specific Computational Models 1

Top 12 of 12 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Taiwan RedEye Biomedical Inc.'s patent record in context - here's where to go next.

Taiwan RedEye Biomedical Inc.'s lead technology class is G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties), 93.3% of its portfolio - see every assignee active in that class. Explore G01N
Ranked #19,214 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Taiwan RedEye Biomedical Inc. against TVI Entwicklung & Produktion GMBH, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 48.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.